A dermatologist may distinguish a mole from a tumor based on a glance, the way a cook can tell parsley from cilantro by sniffing it. But medical students don’t have enough experience to make such intuitive diagnoses. Michael Kolodney, who chairs West Virginia University’s Department of Dermatology, has developed a smartphone app to cultivate that intuition in medical students sooner.
Antar Jutla, associate professor of civil and environmental engineering at West Virginia University, is part of a British-led humanitarian team that is working to predict and prevent a major outbreak of cholera in war-torn Yemen.
Imagine taking courses on some of the hottest topics today—energy, banking, child care and the dark side new media—from some of the best professors on campus.
Albeir Mousa, a professor of vascular surgery at West Virginia University, has used an innovative, faster method for ruling out DVT in patients before they have an ultrasound. He and his research team found that measuring the level of a specific protein—called D-dimer—in a patient’s blood may predict whether a time-intensive ultrasound is warranted. The “Annals of Vascular Surgery” has published the team’s results.
This season’s Festival of Ideas at West Virginia University addresses topics at the forefront of the American conversation—from suicide prevention and genetically engineered food to civic engagement and why we should resist hate with free speech instead of censorship.
Four WVU Medicine hospitals have been recognized by U.S. News & World Report as part of its 2018-19 Best Hospitals in the United States.
Two WVU researchers have found that babies exposed to Suboxone in utero fared as well as, or better than babies exposed to more conventional addiction treatments, such as treatment with methadone or Subutex.
What do one in five breast cancers have in common? Large amounts of a protein called HER2 (or human epidermal growth factor receptor 2). “Every healthy cell produces a normal amount of HER2, but HER2 is produced 10 to 20 times more in a cancer cell,” said Yehenew Agazie, an associate professor of biochemistry at the West Virginia University School of Medicine.
West Virginia University (WVU) has been selected as the first site for an innovative clinical trial to treat Alzheimer’s disease. Ali Rezai, M.D., director of the WVU Rockefeller Neuroscience Institute, will lead the initiative in collaboration with INSIGHTEC, an Israel-based medical technology company who received approval by the U.S. Food and Drug Administration (FDA) to begin the clinical trial using focused ultrasound to treat Alzheimer’s.
Based at West Virginia University’s Eastern Campus in Martinsburg, Joy Buck, a WVU School of Nursing professor, and her collaborators will gather real-time data about overdose trends and assess the cultural barriers to—and facilitators of—overdose prevention. The findings gleaned from her pilot project may prove useful in other rural areas across the nation.